Scientific article
OA Policy
French

La maladie d'Erdheim Chester : un diagnostic différentiel de fibrose rétropéritonéale

Published in

Revue médicale suisse, vol. 13, no. 557, p. 743-747

Publication date

2017

Abstract

Erdheim-Chester disease is a rare multisystemic non-Langerhans histiocytosis with about 500 reported cases. Typical features include retroperitoneal and perirenal fibrosis (hairy kidney), periaortitis with a coated aorta, osteosclerosis of the lower limbs, and sometimes exophthalmia or diabetes insipidus. Histology is the cornerstone for diagnosis showing an infiltrate with foamy histiocytes and occasional multinucleated giant cells (Touton cells). There is no standard treatment regimen, current options include corticosteroids, interferon alpha, systemic chemotherapy, and radiation therapy ; however, a better understanding of the pathophysiological mechanisms has allowed the emergence of novel targeted treatments such as vemurafenib, imatinib, and anakinra.

Citation (ISO format)

ANDRE, Raphaël, SEEBACH, Jorg Dieter. La maladie d’Erdheim Chester : un diagnostic différentiel de fibrose rétropéritonéale. In: Revue médicale suisse, 2017, vol. 13, n° 557, p. 743–747.

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1660-9379
494views
382downloads

Technical informations

Creation

16/08/2017 11:15:00

First validation

16/08/2017 11:15:00

Update

09/01/2025 10:28:44

Status update

09/01/2025 10:28:44

Last indexation

09/01/2025 10:32:56
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated